[1]
2021. Immunological and Virological Outcomes among Treatment Experienced HIV-Infected Patients on Dolutegravir Regimen in Tanzania. Tanzania Medical Journal. 32, 4 (Nov. 2021), 28–39. DOI:https://doi.org/10.4314/tmj.v32i4.512.